Artemis Medicare Q1 Profit Jumps 48% on Strong Margin Expansion
The hospital chain's Q1 FY27 profit soared 48.3% year-on-year, driven by a significant 260 basis point improvement in net profit margin.
Artemis Medicare Services reported robust Q1 FY27 results, with profit surging 48.3% year-on-year. Revenue grew 12.7%, while net profit margin expanded sharply to 10.9%.
Artemis Medicare Services kicked off FY27 with a powerful earnings beat, as profit growth dramatically outpaced a steady rise in revenue. The Gurugram-based hospital's net profit surged 48.3% year-on-year to ₹31.44 crore, far exceeding the 12.7% revenue growth, signaling a major improvement in profitability.
The company's net profit margin expanded by 260 basis points compared to the same quarter last year, reaching 10.9%. This margin expansion was the key driver of the stellar profit performance. Sequentially, both revenue and profit continued their upward trajectory, growing 2.9% and 3.8% respectively from the previous quarter (Q4 FY26).
A look at the last five quarters shows a clear trend of strengthening financials, with revenue consistently above ₹270 crore for the past four quarters and profit hitting a new high in Q1 FY27.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Period | Jun 2026 | Mar 2026 | Jun 2025 |
| Revenue (₹ Cr) | 287.32YoY +13% | 279.23 | 254.96 |
| Profit (₹ Cr) | 31.44YoY +48% | 30.28 | 21.20 |
| Net Profit Margin (%) | 10.9YoY +31% | 10.8 | 8.3 |
Key Points
- The trailing twelve-month (TTM) revenue stands at ₹1,113.61 crore with a TTM net profit margin of 10.2%.
- The stock has delivered strong returns, gaining 29.2% over the past year and 159.5% over three years.
- The company maintains a healthy balance sheet with a low debt-to-equity ratio of 0.26 and a solid return on capital employed (ROCE) of 15.83%.
Despite the impressive operational performance, the stock trades at a significant discount to its industry peers, with a P/E of 31.4 compared to the healthcare industry average of 67.5. The challenge for management will be to sustain this new level of elevated profitability through the coming quarters.
Live Chart
· ARTEMISMED
(BSE)
ISIN: INE025R01021
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.